Topics
-
Clinical Trials That Could Turn the Tide in 2025
The biotech industry faces uncertainty in 2025, but a wave of clinical trial results could turn the tide. Keep an…
Read More » -
How AI Will Transform the Pharmaceutical Industry by 2025
By 2025, artificial intelligence (AI) is expected to drastically transform the pharmaceutical industry, enhancing drug development and clinical trial processes.…
Read More » -
Navigating the Evolving Pharma Landscape: Insights for Industry Leaders
The 2020s have brought significant challenges and opportunities for pharma companies, particularly with the rise of remote work, AI integration,…
Read More » -
Surge in FDA Approvals of AI-Enabled Medical Devices: A Decade of Growth
The number of FDA-authorized AI-enabled medical devices has surged in the past decade, with nearly 1,000 devices approved as of…
Read More » -
AI Revolutionizes Drug Development: Small Biotechs Stand Independently?
As AI reshapes the landscape of drug development, smaller biotech firms are finding ways to thrive without relying heavily on…
Read More » -
Pharma Reputation Affects Physicians’ Prescription Decisions
A recent survey conducted by WE Communications has highlighted that physicians consider more than just the therapeutic effects of medications…
Read More » -
Radiopharmaceutical Trials: The Importance of Site Selection and Patient Support
The success of radiopharmaceutical trials relies heavily on effective site selection and robust patient support, as these elements significantly enhance…
Read More » -
How Generative AI is Revolutionizing Clinical Trial Processes
Generative AI is poised to transform how clinical trials are conducted, enhancing efficiency and precision. Rune Bergendorff, a partner at…
Read More » -
Exscientia Launches AI-Powered Platform to Transform Drug Discovery
Exscientia plc is expanding its partnership with Amazon Web Services (AWS) to launch a platform that combines generative AI drug…
Read More » -
Pharma’s Underutilization of Social Media: Insights from Healthcare Providers
Pharmaceutical companies are missing out on a valuable opportunity to connect with doctors and patients through social media, according to…
Read More »